Selexipag
Spécifications
475086-01-2Numéro CAS
809-991-1Numéro CE
2-[4-[(5,6-diphenylpyrazin-2-yl)-propan-2-ylamino]butoxy]-N-methylsulfonylacetamideNom IUPAC
C26H32N4O4SFormule chimique
496.6 g/molMasse molaire
Selexipag; 475086-01-2; NS-304; Uptravi; ACT-293987; NS 304; ACT 293987; 5EXC0E384L; 2-[4-[(5,6-Diphenyl-2-pyrazinyl)(1-methylethyl)amino]butoxy]-N-(methylsulfonyl)acetamide; ACT293987; CHEBI:90844; DTXSID301027959; 2-{4-[(5,6-diphenylpyrazin-2-yl)(propan-2-yl)amino]butoxy}-N-(methanesulfonyl)acetamide; 2-{4-[(5,6-diphenylpyrazin-2-yl)(propan-2-yl)amino]butoxy}-N-methanesulfonylacetamide; 2-(4-((5,6-Diphenylpyrazin-2-yl)(propan-2-yl)amino)butoxy}-n-(methanesulfonyl)acetamide; selexipagum; 2-(4-((5,6-di(phenyl)pyrazin-2-yl)-propan-2-ylamino)butoxy)-N-methylsulfonylacetamide; 2-(4-((5,6-Diphenyl-2-pyrazinyl)(1-methylethyl)amino)butoxy)-N-(methylsulfonyl)acetamide; 2-(4-((5,6-diphenylpyrazin-2-yl)(propan-2-yl)amino)butoxy)-N-methanesulfonylacetamide; 2-[4-[[5,6-di(phenyl)pyrazin-2-yl]-propan-2-ylamino]butoxy]-N-methylsulfonylacetamide; 2-(4-((5,6-DIPHENYLPYRAZIN-2-YL)(PROPAN-2-YL)AMINO)BUTOXY)-N-(METHANESULFONYL)ACETAMIDE; Uptravi Titration Pack; RefChem:58598; Selexipag TITRATION PACK; B01AC27; DTXCID501513526; 2-(4-((5,6-diphenylpyrazin-2-yl)(isopropyl)amino)butoxy)-N-(methylsulfonyl)acetamide; MFCD10567093; 2-[4-[(5,6-diphenylpyrazin-2-yl)-propan-2-ylamino]butoxy]-N-methylsulfonylacetamide; NS-304;ACT-293987; Selexipag [USAN:INN]; UNII-5EXC0E384L; C26H32N4O4S; 2-[4-[(5,6-Diphenyl-2-pyrazinyl)(1-methylethyl)amino]butoxy]-N-(methylsulfonyl)acetamide; 2-[4-[(5,6-Diphenylpyrazin-2-yl)(isopropyl)amino]butoxy]-N-(methylsulfonyl)acetamide; ACT 293987; NS 304; Uptravi;; Uptravi (TN); Selexipag (Standard); NS-304(Selexipag); Selexipag(NS-304); SELEXIPAG [INN]; SELEXIPAG [JAN]; SELEXIPAG [MI]; SELEXIPAG [USAN]; NS-304(Selexipag)?; SELEXIPAG [WHO-DD]; Selexipag (JAN/USAN/INN); SCHEMBL674122; CHEMBL238804; GTPL7552; orb1304415; SELEXIPAG [ORANGE BOOK]; SCHEMBL29360518; QXWZQTURMXZVHJ-UHFFFAOYSA-N; GLXC-27569; HMS5082O03; EX-A7991; BDBM50235383; EBC-13811; HY-14870R; s3726; AKOS024457572; CCG-269668; CS-3774; DB11362; SB17055; 2-{4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}-N-(methylsulfonyl)acetamide; NCGC00370833-01; NCGC00370833-02; AC-30209; BS-16872; FD106425; HY-14870; SY236548; DB-119997; NS00069732; D09994; EN300-7378417; BRD-K21191422-001-01-5; Q15424759; 2-[4-[(5,6-Diphenyl-2-pyrazinyl)(isopropyl)amino]butoxy]-N-(methylsulfonyl)acetamide; 2-[4-[(5,6-diphenylpyrazin-2-yl)-isopropyl-amino]butoxy]-N-methylsulfonyl-acetamide; Selexipag MicronizedSynonymes
Produits contenant Selexipag
업트라비정600마이크로그램(셀렉시팍)업트라비정400마이크로그램(셀렉시팍)업트라비정800마이크로그램(셀렉시팍)업트라비정200마이크로그램(셀렉시팍)ウプトラビ錠0.2mg/ウプトラビ錠0.4mg/ウプトラビ錠0.8mgウプトラビ錠小児用0.05mgUPTRAVI 800 MCG COMPRIMIDOS RECUBIERTOS CON PELICULAUPTRAVI 600 MCG COMPRIMIDOS RECUBIERTOS CON PELICULAUPTRAVI 400 MCG COMPRIMIDOS RECUBIERTOS CON PELICULAUPTRAVI 200 MCG COMPRIMIDOS RECUBIERTOS CON PELICULAUPTRAVI 1600 MCG COMPRIMIDOS RECUBIERTOS CON PELICULAUPTRAVI 1400 MCG COMPRIMIDOS RECUBIERTOS CON PELICULA
Page 1 sur 6
Entreprises vendant Selexipag
ML
MSN LaboratoriesIndiaSI
Sinoway Industrial Co.Ltd.ChinaAP
Alicorn Pharmaceutical Co., LtdChinaSD
SHIJIAZHUANG DINGMIN PHARMACEUTICAL SCIENCES CO., LTDChinaAP
Apotex PharmachemCanadaCH
ChemoSpainNC
Nuray Chemicals Private LimitedIndiaPage 1 sur 3